Posts

Psychedelic Business Spotlight - April 29

Psychedelic Business Spotlight – April 29

,
This week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.
Psychedelic Business News Spotlight - December 24

Psychedelic Business Spotlight – December 24

,
This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.
FDA Green Lights Tryp Therapeutics' Psilocybin Study on Binge Eating DisorderShutterstock.com

FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating Disorder

The pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9 billion market potential for such a treatment.
Psychedelic Business Spotlight: November 5

Psychedelic Business Spotlight: November 5

,
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Psychedelic Business Spotlight: August 13, 2021

Psychedelic Business Spotlight: August 13, 2021

,
This week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain,...
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 9, 2021

,
This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.